Skip to main content
WH

Waire Health Ltd

Waire Health develops the SensArm, a medical-grade wearable vital signs monitor that autonomously tracks multiple parameters, including blood pressure and ECG, without requiring network connectivity. This technology addresses the critical issue of missed deterioration signs in patients, enabling timely alerts and reducing healthcare costs through continuous real-time monitoring.

Founded 20153500+ followers
Updated 20 months ago

Funding

$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

E
Funding rounds are not available yet.

Founders

Product

Problem

Hospital patients can experience adverse events due to missed signs of deterioration, especially outside of intensive care settings. Current vital signs monitoring often relies on intermittent manual checks, which may fail to detect subtle but critical changes in a patient's condition, leading to delayed intervention and increased healthcare costs. Existing wearable monitors often require continuous network connectivity, limiting their utility in areas with poor or no network coverage and creating potential security vulnerabilities.

Solution

Waire Health's SensArm is a medical-grade, wearable vital signs monitor that autonomously tracks a comprehensive set of physiological parameters, including cuffless blood pressure estimation, ECG, respiration rate, temperature, oxygen saturation, and body position. The device operates independently of network connectivity, enabling continuous real-time monitoring even in areas with limited or no network access. Onboard AI and machine learning algorithms analyze the data to identify trends and potential deterioration, generating clinical risk scores based on NEWS2, PEWS, or MEWS criteria every 120 seconds. The system alerts healthcare providers to critical changes while suppressing false alarms, facilitating timely intervention and improved patient outcomes.

Target Audience

The primary target audience includes hospitals and healthcare providers seeking continuous, real-time vital signs monitoring for patients in general wards and at-home care settings, as well as elderly patients and those with chronic conditions requiring remote monitoring.

Features

  • Cuffless blood pressure estimation using proprietary algorithms
  • Continuous ECG monitoring with beat-to-beat heart rate variability analysis
  • Multi-parameter monitoring including respiration rate, temperature, oxygen saturation, and 3-axis body position
  • Autonomous operation without reliance on continuous network connectivity
  • Local AI and supervised machine learning models for real-time analysis and risk scoring
  • Dynamic task-based workflow system using a modified form of blockchain for data management
  • Integration with common EHR systems via containerized local VM deployment or cloud infrastructure
  • Waterproof design with a 5-day battery life and antimicrobial Gorilla Glass
  • Encrypted Bluetooth 5 for secure data transmission
This profile is AI-generated and may contain inaccuracies.